Abuja – Nigeria has introduced lenacapavir, a new long‑acting injectable medicine for HIV prevention, marking a significant step in the country’s efforts to reduce new infections and advance national HIV goals. The Federal Ministry of Health and Social Welfare launched the intervention with support from World Health Organization (WHO), the Global Fund, United States President’s Emergency Plan for AIDS Relief (PEPFAR) and partners.

Abuja, Nigeria – With technical support from the World Health Organization (WHO), Nigeria is closing tuberculosis (TB) detection gaps, expanding access to testing and treatment, and strengthening services for vulnerable populations.

A case that shows the impact
In Nasarawa State, 21‑year‑old Gwamkat Rifkatu (name changed) developed a persistent cough that her family initially dismissed as minor. Weeks passed without improvement, leaving her weak and unable to work.

Praia - The document that will guide the World Health Organization (WHO) activities in Cabo Verde for 2026–2027 was signed on 31 March 2026 by the Minister of Health, Jorge Figueiredo, and the WHO Representative, Ann Lindstrand. 

Namibia is stepping up its fight against malaria following a sharp rise in cases in early 2026, with health authorities and partners working around the clock to contain the outbreak and protect at-risk communities.

A worrying rise in cases
After years of steady progress in eliminating malaria, the country is now experiencing a resurgence. Heavier and unusual rainfall has created ideal conditions for mosquitoes to breed, enabling the disease to spread more rapidly, including in areas that previously had little or no transmission.

Maseru—For 35-year-old Mokeseng Habasisi, being the first man in Lesotho to receive Lenacapavir, a groundbreaking long-acting HIV prevention injection, was a remarkable and life-changing moment. 

“I am happy to be amongst the first recipients stepping forward to embrace new prevention methods”, says Habasisi.

Praia, Cabo Verde — The World Health Organization (WHO) actively participated in the First National Meeting of Pharmacovigilance Focal Points, held on 25–26 March 2026, playing a central role in strengthening national capacities and promoting best practices for medicine safety.

Ghana, like many countries in the WHO Africa Region, remains vulnerable to public health emergencies due to underlying vulnerabilities and challenging health systems. Between 2022 to 2025, the country has responded to several disease outbreaks including meningitis, dengue fever, cholera, Marburg virus disease, Lassa fever and mpox. These outbreaks placed considerable pressure on the public health system, often disrupting the delivery of essential health care in the most affected areas. 

The Ministry of Health and Social Services (MoHSS), with technical support from the World Health Organization (WHO), has convened a national stakeholders’ meeting to review the 2005 National Mental Health Policy and to develop a comprehensive implementation plan.

Arusha - With support from the Pandemic Fund, the Government of the United Republic of Tanzania, through the Ministry of Health and in collaboration with the World Health Organization (WHO) and partners, convened an International Health Regulations (IHR) Technical Working Group (TWG) meeting in Arusha. The meeting brought together key stakeholders to review progress and prioritize actions to strengthen national systems for public health emergency preparedness and response.